Abstract
Rationale
Phospholamban (PLN) is an inhibitor of cardiac sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA2a). PLN knockout (PLN-KO) enhances sarcoplasmic reticulum (SR) Ca2+ load and Ca2+ leak. Conversely, PLN-KO accelerates Ca2+ sequestration and aborts arrhythmogenic spontaneous Ca2+ waves (SCWs). An important question is whether these seemingly paradoxical effects of PLN-KO exacerbate or protect against Ca2+-triggered arrhythmias.
Objective
We investigate the impact of PLN-KO on SCWs, triggered activities, and stress-induced ventricular tachyarrhythmias (VTs) in a mouse model of cardiac ryanodine receptor (RyR2)-linked catecholaminergic polymorphic ventricular tachycardia (CPVT).
Methods and Results
We generated a PLN-deficient, RyR2 mutant mouse model (PLN−/−/RyR2-R4496C+/−) by crossbreeding PLN-KO mice with CPVT-associated RyR2-R4496C mutant mice. Ca2+ imaging and patch-clamp recording revealed cell-wide propagating SCWs and triggered activities in RyR2-R4496C+/− ventricular myocytes during SR Ca2+ overload. PLN-KO fragmented these cell-wide SCWs into mini-waves and Ca2+ sparks, and suppressed triggered activities evoked by SR Ca2+ overload. Importantly, these effects of PLN-KO were reverted by partially inhibiting SERCA2a with 2,5-Di-tert-butylhydroquinone (tBHQ). However, Bay K, caffeine, or Li+ failed to convert mini-waves to cell-wide SCWs in PLN−/−/RyR2-R4496C+/− ventricular myocytes. Furthermore, ECG analysis showed that PLN-KO mice are not susceptible to stress-induced VTs. On the contrary, PLN-KO protected RyR2-R4496C mutant mice from stress-induced VTs.
Conclusions
Our results demonstrate that despite severe SR Ca2+ leak, PLN-KO suppresses triggered activities and stress-induced VTs in a mouse model of CPVT. These data suggest that breaking up cell-wide propagating SCWs by enhancing Ca2+ sequestration represents an effective approach for suppressing Ca2+-triggered arrhythmias.
Keywords: Sarcoplasmic reticulum, ryanodine receptor, phospholamban, Ca2+ waves, Ca2+ leak, Ca2+-triggered arrhythmias
INTRODUCTION
In the heart excitation-contraction coupling is mediated by a mechanism known as Ca2+-induced Ca2+ release (CICR)1–3. In this process, membrane depolarization activates the voltage-dependent L-type Ca2+ channel (LTCC), resulting in a small influx of external Ca2+ into the cytosol. This Ca2+ then binds to the cardiac Ca2+ release channel/ryanodine receptor (RyR2) and opens the channel, leading to a large release of Ca2+ from the sarcoplasmic reticulum (SR). In addition to CICR, it has long been known that SR Ca2+ release can occur spontaneously under conditions of SR Ca2+ overload in the absence of membrane depolarizations4–9. A number of conditions, including excessive beta-adrenergic stimulation, Na+ overload, elevated extracellular Ca2+ concentrations, and fast pacing can result in SR Ca2+ overload which, in turn, can trigger spontaneous SR Ca2+ release in the form of propagating Ca2+ waves4–9. It has also long been recognized that these spontaneous Ca2+ waves (SCWs) can alter membrane potential via activation of the electrogenic Na+/Ca2+ exchanger (NCX), leading to delayed afterdepolarizations (DADs), triggered activities, and triggered arrhythmias8, 10–12. In fact, SCW-evoked DADs are a major cause of ventricular tachyarrhythmias (VTs) in heart failure12–14. SCW-evoked DADs also underlie the cause of catecholaminergic polymorphic ventricular tachycardia (CPVT) associated with mutations in RyR2 and cardiac calsequestrin (CASQ2)15. CPVT-causing RyR2 or CASQ2 mutations have been shown to enhance the propensity for SCWs and DADs15. Given their critical role in arrhythmogenesis, suppressing SCWs represents a promising therapeutic strategy for the treatment of Ca2+-triggered arrhythmias.
Since RyR2 mediates SCWs, inhibiting the RyR2 channel would be effective in suppressing SCWs. Indeed, reducing the RyR2 activity by tetracaine has been shown to inhibit spontaneous Ca2+ release16. Further, it has recently been shown that flecainide, a Na+ channel blocker, suppresses SCWs in cardiac cells and CPVT in both mice and humans by modifying the gating of the RyR2 channel17–19. Flecainide reduces the duration and increases the frequency of openings of the RyR2 channel. Similarly, we have recently shown that carvedilol, a non-selective beta-blocker, also reduces the duration and increases the frequency of RyR2 openings, and suppresses SCWs and CPVT in mice20. Interestingly, by modifying the gating of RyR2, flecainide increases the frequency and reduces the mass of Ca2+ sparks without affecting the SR Ca2+ content18. These actions of flecainide effectively break up cell-wide propagating SCWs into non-propagating spontaneous Ca2+ release events (mini-waves or Ca2+ sparks)18, 19. These observations have led to the suggestion that breaking up SCWs by modifying RyR2 gating represents an effective approach to suppressing SCW-evoked DADs and triggered arrhythmia19.
The sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA2a) in the heart also plays a critical role in determining the initiation and propagation of SCWs21–25. It has been shown that increasing the activity of SERCA2a by removing phospholamban (PLN), an inhibitor of SERCA2a, elevated SR Ca2+ load and markedly enhanced the frequency and amplitude of Ca2+ sparks26–28. Interestingly, despite severe SR Ca2+ leak, no spontaneous cardiac arrhythmias in PLN knockout (PLN-KO) mice have been reported. Further, cell-wide propagating SCWs were hardly observed or frequently aborted in PLN-KO cardiomyocytes29. These observations raise an important question as to whether accelerating SR Ca2+ uptake by removing PLN is pro-arrhythmic or anti-arrhythmic. On one hand, PLN-KO elevates SR Ca2+ content and increases SR Ca2+ leak, which would enhance the propensity for Ca2+ leak-induced DADs. On the other hand, PLN-KO aborts SCWs, which would suppress SCW-induced DADs and triggered activities. To address this seemingly paradoxical question, we employed the PLN-KO mice along with the CPVT RyR2-R4496C mutant mice that are prone to SCWs and DAD-evoked VTs20, 26. We examined the impact of PLN-KO on the spatial and temporal properties of SCWs and the occurrence of triggered activities in ventricular myocytes expressing the RyR2-R4496C mutant. We also determined the effect of PLN-KO on the susceptibility to stress-induced VTs in the CPVT RyR2-R4496C mutant mice. We found that the removal of PLN breaks SCWs and suppresses triggered activities in the RyR2-R4496C mutant ventricular myocytes, and diminishes stress-induced VTs in the RyR2-R4496C mutant mice. These data are consistent with the notion that breaking up propagating SCWs by accelerating SR Ca2+ uptake is effective in suppressing Ca2+-triggered arrhythmias.
METHODS
To determine whether removal of PLN alters the spatial and temporal profiles of intracellular Ca2+ signalling in RyR2 R4496C+/− mutant ventricular myocytes, we crossbred the RyR2-R4496C+/− mutant mice with the PLN knockout (PLN-KO) mice (PLN−/−) to produce a PLN deficient mouse line expressing the RyR2 R4496C+/− mutation (PLN−/−/RyR2-R4496C+/−). Detailed methods are provided in the Online Supplement.
RESULTS
PLN-KO breaks cell-wide propagating spontaneous Ca2+ waves in isolated RyR2-R4496C+/− mutant ventricular myocytes
It is well known that cardiomyocytes display spontaneous Ca2+ waves (SCWs) propagating throughout the entire cell under the conditions of SR Ca2+ overload4–8. Interestingly, PLN-KO markedly alters the pattern of spontaneous Ca2+ release by breaking up the cell-wide propagating SCWs into multiple, localized mini-waves and sparks29. To determine whether PLN-KO is also able to break up cell-wide propagating SCWs in ventricular myocytes harbouring a CPVT-causing RyR2 mutation R4496C that is prone to spontaneous Ca2+ release, we crossbred the PLN-KO mice (PLN−/−) with the RyR2-R4496C mutant heterozygous mice (RyR2-R4496C+/−) to generate double mutant mice, PLN−/−/RyR2-R4496C+/−. Ventricular myocytes were isolated from the RyR2-R4496C+/− and PLN−/−/RyR2-R4496C+/− mice, loaded with fluo-4 AM, and perfused with elevated extracellular Ca2+ (6 mM) to induce SR Ca2+ overload and SCWs. Intracellular Ca2+ dynamics were monitored using line-scan confocal Ca2+ imaging. As shown in Fig.1A, SCWs in RyR2-R4496C+/− ventricular myocytes originated from the middle (or either end) of the cell and propagated across the entire cell, similar to those reported previously20, 30–32. On the other hand, SCWs in the PLN−/−/RyR2-R4496C+/− ventricular myocytes frequently and simultaneously occurred at multiple sites and aborted shortly after their initiation without propagating across the entire cell. They appeared as short-lived mini-waves or clusters of Ca2+ sparks (Fig. 1B). Similar spontaneous Ca2+ release events were also detected in ventricular myocytes from PLN−/− mouse hearts (Fig. 1C), consistent with those shown previously29. Further, this impact of PLN-KO was not limited to SCWs induced by elevated external Ca2+. We found that PLN-KO also breaks SCWs induced by isoproterenol (Online Fig. I). Taken together, these observations indicate that PLN-KO is able to break up cell-wide SCWs in the RyR2-R4496C+/− mutant ventricular myocytes.
Figure 1. PLN-KO breaks cell-wide propagating spontaneous Ca2+ waves in isolated ventricular myocytes.
Ventricular myocytes were isolated from RyR2-R4496C+/− mutant mice, the PLN deficient, RyR2-R4496C+/− mice (PLN−/−/RyR2-R4496C+/−) or the PLN−/− mice, and loaded with the fluorescent Ca2+ indicator dye fluo-4, AM. The fluo-4 loaded cells were perfused with KRH buffer containing 6 mM extracellular Ca2+ to induce SR Ca2+ overload. Store overload induced spontaneous SR Ca2+ release events were detected by line-scan confocal Ca2+ imaging.
Representative line-scan images of spontaneous Ca2+ release in isolated RyR2-R4496C+/− (n=39) (A), PLN−/−/RyR2-R4496C+/− (n=43) (B), and PLN−/− (n=9) (C) ventricular myocytes are shown.
PLN-KO fragments cell-wide propagating SCWs in ventricular myocytes in intact RyR2-R4496C+/− hearts
The markedly altered spatial and temporal profiles of intracellular Ca2+ dynamics in PLN−/−/RyR2-R4496C+/− or PLN−/− ventricular myocytes may have resulted from cellular damage during cell isolation. To avoid this potential problem, we carried out line-scan confocal Ca2+ imaging of epicardial ventricular myocytes in intact hearts33. Rhod-2 AM loaded hearts from the RyR2-R4496C+/−, PLN−/−/RyR2-R4496C+/−, and PLN−/− mice were Langendorff-perfused with elevated extracellular Ca2+ (6 mM) and paced at 6 Hz to induce SR Ca2+ overload and subsequent SCWs. As seen in Fig. 2A (top panel), after interruption of electrical pacing, SCWs occurred at 1 or 2 sites and propagated throughout the entire cell in ventricular myocytes in intact RyR2-R4496C+/− hearts. Analysis of the spatially averaged fluorescence revealed well-separated spontaneous Ca2+ release events with amplitudes similar to that of stimulated Ca2+ transients (Fig. 2A, bottom panel). On the other hand, spontaneous Ca2+ release in ventricular myocytes in intact PLN−/−/RyR2-R4496C+/− (Fig. 2B, top panel) or PLN−/− (Online Fig. II, top panel) hearts frequently occurred at multiple sites as mini-waves or clusters of Ca2+ sparks. Analysis of spatially averaged fluorescence showed numerous spontaneous Ca2+ release events with amplitudes much smaller than that of the stimulated Ca2+ transients (Fig. 2B, Online Fig. II, bottom panels). This pattern of spontaneous Ca2+ release observed in ventricular myocytes in the intact PLN−/−/RyR2-R4496C+/− or PLN−/− heart is very similar to that seen in isolated cells (Fig. 1). Thus, the distinct features of spontaneous Ca2+ release in isolated PLN−/−/RyR2-R4496C+/− or PLN−/− myocytes reflect the intrinsic properties of intracellular Ca2+ handling of these cells, rather than reflecting the consequences of cellular damage during cell isolation.
Figure 2. PLN-KO fragments cell-wide propagating spontaneous Ca2+ waves in intact hearts.
Intact hearts isolated from RyR2-R4496C+/− or PLN−/−/RyR2-R4496C+/− mice were loaded with Rhod-2-AM and Langendorff-perfused with 6 mM extracellular Ca2+ and paced at 6 Hz to induce SR Ca2+ overload. Spontaneous SR Ca2+ release in epicardial ventricular myocytes in intact hearts was monitored by line-scan confocal Ca2+ imaging. Representative line-scan images (top) and the corresponding digitized images (middle) of cell-wide propagating spontaneous Ca2+ waves in intact RyR2-R4496C+/− hearts (A) and of mini-waves and Ca2+ sparks in intact PLN−/−/RyR2-R4496C+/− hearts (B) are shown. Panels A and B (bottom) show the spatial average of fluorescence signal along the scan-line. (C) Definition of wave fluorescence, full duration at half maximum (FDHM), time to peak, amplitude, and rate of rise.
To further assess the spatial and temporal properties of spontaneous Ca2+ release in ventricular myocytes in intact RyR2-R4496C+/−, PLN−/−/RyR2-R4496C+/− and PLN−/− hearts, we analyzed all spontaneous Ca2+ release events (Figs. 2A, 2B, Online Fig. II, middle panels, and Online Fig. III) and classified them into three categories: waves, mini-waves, and sparks, based on their total fluorescence/event. As seen in Fig. 3, RyR2-R4496C+/−, PLN−/−/RyR2-R4496C+/−, and PLN−/− ventricular myocytes displayed very different distributions of spontaneous Ca2+ release events. In RyR2-R4496C+/− ventricular myocytes, 93% of the total spontaneously released Ca2+ was released in the form of Ca2+ waves, while mini-waves and Ca2+ sparks together consisted of only 7% of the total spontaneously released Ca2+ (Fig. 3A,D). In contrast, a majority of the spontaneously released Ca2+ in PLN−/−/RyR2-R4496C+/− or PLN−/− cells was released as mini waves (77–74%), while Ca2+ waves and sparks consisted of 20–25% and 3-2% of the total released Ca2+, respectively (Fig. 3B,C,D). Furthermore, the occurrence of Ca2+ waves was significantly greater in RyR2-R4496C+/− cells than in PLN−/−/RyR2-R4496C+/− or PLN−/− cells (Fig. 3D). On the other hand, the occurrence of mini-waves and Ca2+ sparks was significantly greater in PLN−/−/RyR2-R4496C+/− or PLN−/− cells than in RyR2-R4496C+/− cells (Fig. 3E,F,G). In other words, RyR2-R4496C+/− ventricular myocytes displayed primarily Ca2+ waves, whereas PLN−/−/RyR2-R4496C+/− or PLN−/− ventricular myocytes exhibited predominantly mini-waves and Ca2+ sparks with few Ca2+ waves (Fig. 3A,B,C).
Figure 3. Distribution of spontaneous Ca2+ release events in intact RyR2-R4496C mutant hearts with or without PLN.
Line-scan confocal images were digitized and spontaneous Ca2+ release events were detected and classified using a custom-made program as described in the supplementary methods. (A, B, C) Distribution of spontaneous Ca2+ release events in RyR2-R4496C+/− mutant (A), PLN−/−/RyR2-R4496C+/− (B), and PLN−/− (C) hearts according to their total fluorescence. Three types of spontaneous Ca2+ release events (Ca2+ sparks, mini-waves, and waves) were classified based on the size of the total fluorescence (see Supplementary Methods). The red line represents a Gaussian fit of the distribution of Ca2+ waves in RyR2-R4496C+/− hearts. (D) The overall contribution (%) of sparks, mini-waves, and waves in RyR2-R4496C+/−, PLN−/−/RyR2-R4496C+/−, and PLN−/− hearts. (E, F, G) The occurrence (events/scan) of Ca2+ waves (E), mini-waves (F), and Ca2+ sparks (G) in RyR2-R4496C+/−, PLN−/−/RyR2-R4496C+/−, and PLN−/− hearts. Data shown are mean ± SEM from 19 (PLN−/−), 39 (RyR2-R4496C+/−), and 43 (PLN−/−/RyR2-R4496C+/−) line-scan images (*P < 0.001).
We next determined and compared the properties of Ca2+ waves, mini waves, and Ca2+ sparks in ventricular myocytes in intact RyR2-R4496C+/−, PLN−/−/RyR2-R4496C+/− and PLN−/−hearts. We found that the amplitude, full duration at half maximum (FDHM), and rate of rise of Ca2+ waves or mini waves are significantly greater in RyR2-R4496C+/− cells than in PLN−/−/RyR2-R4496C+/− or PLN−/− cells (Fig. 4A,B). On the other hand, the amplitude and duration of Ca2+ sparks are significantly smaller in RyR2-R4496C+/− cells than in PLN−/−/RyR2-R4496C+/− or PLN−/− cells. Consistent with previously reported data27, PLN-KO increased the amplitude and decreased the FDHM of stimulated Ca2+ transients (Fig. 2, Online Fig. IV). Taken together, our single cell and intact heart Ca2+ imaging studies demonstrate that PLN-KO suppresses SCWs in RyR2-R4496C+/− mutant ventricular myocytes by breaking up cell-wide propagating SCWs into mini-waves and Ca2+ sparks and reducing the amplitude, duration, and rate of rise of SCWs.
Figure 4. Effect of PLN-KO on spontaneous Ca2+ release in intact RyR2-R4496C mutant hearts.
Spontaneous Ca2+ release events in intact RyR2-R4496C+/−, PLN−/−/RyR2-R4496C+/−, and PLN−/− hearts were divided into Ca2+ waves (A), mini-waves (B), and Ca2+ sparks (C) as described in the legend of Fig. 3, and their amplitude (top), full duration at half maximum (FDHM) (middle), and rate of rise (bottom) were compared. Data shown are mean ± SEM from 19–43 line-scan images (#P < 0.01, *P < 0.001, vs RC+/−).
PLN-KO suppresses triggered activities in RyR2-R4496C+/− ventricular myocytes
Spontaneous SR Ca2+ release can lead to DADs, and DADs can trigger action potentials (APs) when the amplitude of a DAD reaches the threshold for Na+ channel activation. Whether spontaneous Ca2+ release can generate DADs with amplitudes that are sufficient to trigger APs depends on the amplitude and rate of rise of the spontaneous Ca2+ release10, 34. The substantially different spatial and temporal properties of spontaneous Ca2+ release in RyR2-R4496C+/− and PLN−/−/RyR2-R4496C+/− cells raise the important question of whether PLN-KO can also affect the occurrence of triggered activities. To address this question, we perfused ventricular myocytes isolated from the RyR2-R4496C+/− and PLN−/−/RyR2-R4496C+/− mice with 6 mM extracellular Ca2+ to induce SR Ca2+ overload and spontaneous Ca2+ release. We then recorded the membrane potential in these cells using the perforated patch current clamp technique. As shown in Fig. 5, RyR2-R4496C+/− ventricular myocytes displayed frequent DADs and spontaneously triggered APs (Figs. 5Aa, C and D), which is consistent with those reported previously31. Interestingly, under the same conditions, PLN−/−/RyR2-R4496C+/− ventricular myocytes exhibited a large number of small DADs, but little or no triggered APs (Figs. 5Ba, C and D). Thus, these observations indicate that PLN-KO suppresses the occurrence of triggered APs in RyR2-R4496C+/− ventricular myocytes.
Figure 5. Effect of PLN-KO on delayed afterdepolarizations and triggered activities.
Ventricular myocytes were isolated from RyR2-R4496C+/− and PLN−/−/RyR2-R4496C+/− hearts and perfused with 6 mM extracellular Ca2+ to induce spontaneous Ca2+ release. Membrane potentials in RyR2-R4496C+/− (A) or PLN−/−/RyR2-R4496C+/− (B) myocytes before (a) and after (b) the treatment with tBHQ, a SERCA2a inhibitor, were recorded using the perforated patch current clamp technique. (C, D) The frequency of spontaneously triggered APs (C) and delayed afterdepolarizations (DADs) (D) in RyR2-R4496C+/− and PLN−/−/RyR2-R4496C+/− ventricular myocytes before (a) and after (b) tBHQ treatment. Data shown are mean ± SEM from 8–12 cells (#P < 0.05, vs RC mice; *P < 0.05, vs -tBHQ). (E) Representative line-scan images of spontaneous Ca2+ release in isolated PLN−/−/RyR2-R4496C+/− ventricular myocytes before (a) and after (b) the treatment with 5 µM tBHQ (n = 21–22 cells) are shown.
Given the close link between SCWs and triggered activities10, 34, the lack of triggered APs in PLN−/−/RyR2-R4496C+/− cells is likely attributable to the absence of SCWs in these cells. To test this possibility, we mimicked the action of PLN by partially inhibiting SERCA2a with 2,5-Di-tert-butylhydroquinone (tBHQ, 5 µM), a SERCA2a inhibitor. As shown in Fig. 5E, partial inhibition of SERCA2a by tBHQ in PLN−/−/RyR2-R4496C+/− ventricular myocytes converted multiple and frequent mini-waves into cell-wide propagating SCWs similar to those observed in RyR2-R4496C+/− ventricular myocytes. Importantly, the tBHQ treatment increased the occurrence of triggered APs (Figs. 5Bb, C,D) in PLN−/−/RyR2-R4496C+/− ventricular myocytes. On the other hand, the tBHQ treatment did not markedly affect the occurrence of DADs or triggered APs in RyR2-R4496C+/− cells (Figs. 5Ab,C,D). Therefore, these data suggest that PLN-KO suppresses triggered activities by breaking up cell-wide SCWs.
Role of RyR2, LTCC, NCX, and SR Ca2+ load in breaking cell-wide SCWs in PLN−/−/RyR2-R4496C+/− ventricular myocytes
The conversion of mini-waves to cell-wide SCWs by tBHQ in PLN−/−/RyR2-R4496C+/− cells also suggests that enhanced SERCA2a activity as a consequence of PLN-KO is an important determinant of the occurrence of mini-waves. However, it is possible that PLN-KO may also lead to compensatory changes in the expression of Ca2+ handling proteins, which may in turn contribute to the genesis of mini-waves in PLN−/−/RyR2-R4496C+/− cells. To test this possibility, we assessed the expression level of RyR2, LTCC, SERCA2a, and NCX proteins in the RyR2-R4496C+/− and PLN−/−/RyR2-R4496C+/− hearts using immunoblotting analysis. As shown in Fig. 6A, there were no significant differences in their expression levels except for RyR2 that exhibited a slightly higher (~10%, P<0.05) expression in PLN−/−/RyR2-R4496C+/− hearts than in RyR2-R4496C+/− hearts.
Figure 6. Role of RyR2, LTCC, NCX, and SR Ca2+ load in the generation of mini-waves in PLN−/−/RyR2-R4496C+/− ventricular myocytes.
(A) Whole heart homogenates were prepared from RyR2-R4496C+/− and PLN−/−/RyR2-R4496C+/− mutant mice and used for immunoblotting analysis using antibodies against RyR2, LTCC, SERCA2a, NCX or β-actin. Data shown are mean ± SEM (n=3, *P < 0.05, vs RyR2-R4496C+/−). (B, C, D) Ventricular myocytes were isolated from PLN−/−/RyR2-R4496C+/− hearts and loaded with the fluorescent Ca2+ indicator dye fluo-4-AM. Representative line-scan images of spontaneous Ca2+ release induced by elevated extracellular Ca2+ (6 mM) in PLN−/−/RyR2-R4496C+/− cells before (a) and after (b) the treatment with Bay K (B), caffeine (C), and LiCl (replacing NaCl in KRH) (D) (n = 14–18 cells) are shown. Note that none of these treatments converted mini-waves to cell-wide SCWs. (E) SR Ca2+ contents in fluo-4-AM loaded RyR2-R4496C+/− (a), PLN−/−/RyR2-R4496C+/− (b), and PLN−/− (c) ventricular myocytes were estimated by measuring the amplitude of caffeine (20mM) induced Ca2+ transients (d). Data shown are mean ± SEM (n=12–18) (*P < 0.05, vs RyR2-R4496C+/−).
It is also possible that PLN-KO may break SCWs by altering the activity of LTCC, RyR2, or NCX in addition to SERCA2a. For instance, mini-waves could result from reduced activity of LTCC or RyR2, which would reduce Ca2+ influx and SR Ca2+ release, and thus the propagation of Ca2+ waves. Further, mini-waves could also result from increased activity of NCX, which would enhance Ca2+ removal, and thus reduce SR Ca2+ content and SR Ca2+ release. To test these possibilities, we assessed the impact of Bay K 8644 (a LTCC agonist), caffeine (a RyR2 agonist), and Li+ (an inhibitor of NCX) on spontaneous SR Ca2+ release in PLN−/−/RyR2-R4496C+/− ventricular myocytes. In sharp contrast to tBHQ, Bay K, caffeine, or Li+ failed to convert mini-waves into cell-wide SCWs in PLN−/−/RyR2-R4496C+/− cells (Fig. 6B,C,D).
The SR Ca2+ content is also a critical determinant of spontaneous Ca2+ waves35, 36. Accordingly, we determined the SR Ca2+ content in RyR2-R4496C+/−, PLN−/−/RyR2-R4496C+/−, and PLN−/− cells. We found that PLN−/−/RyR2-R4496C+/− and PLN−/− cells displayed significantly higher SR Ca2+ content than RyR2-R4496C+/− cells (Fig. 6E). Thus, enhanced SERCA2a activity, rather than reduced SR Ca2+ content, decreased LTCC or RyR2 activity, or increased NCX activity, is a major contributor to the break-up of cell-wide SCWs.
PLN-KO protects the RyR2-R4496C+/− mice from stress-induced VTs
It has been shown that the RyR2-R4496C mutant mice are highly susceptible to CPVT, which is caused by DAD-induced triggered activities20, 30–32. The lack of triggered activities in PLN−/−/RyR2-R4496C+/− ventricular myocytes upon SR Ca2+ overload raises the possibility that PLN-KO may also suppress CPVT. To directly test this possibility, we recorded ECG in WT littermates, RyR2-R4496C+/−, RyR2-R4496C+/+, PLN−/−/RyR2-R4496C+/−, PLN−/−/RyR2-R4496C+/+, and PLN−/− mice before and after the injection of a mixture of caffeine and epinephrine. Similar to those reported previously20, caffeine and epinephrine induced long-lasting ventricular tachyarrhythmias (VTs) in RyR2-R4496C+/− mice, but not in their WT littermates (Fig. 7). The RyR2-R4496C+/+ homozygous mice are especially vulnerable to stress-induced VTs, displaying sustained VTs for the entire 30 min-period of recording after the injection of the triggers20. Remarkably, caffeine and epinephrine induced little or no VTs in the PLN−/− mice or PLN−/−/RyR2-R4496C+/− mice, and only short-lasting VTs in the PLN−/−/RyR2-R4496C+/+ mice (Fig.8). These data indicate that PLN-KO mice are not susceptible to CPVT, and that PLN-KO protects the RyR2-R4496C mutant mice from stress-induced VTs.
Figure 7. RyR2-R4496C+/− mice are susceptible to CPVT.
Representative ECG recordings of WT littermates (A) and RyR2-R4496C+/− (B) mice before (a) and after (b) the injection of epinephrine (1.6 mg/kg) and caffeine (120 mg/kg). VT duration (%) in WT littermates and RyR2-R4496C+/− mutant mice within each 3-min (C) or 30-min (D) period of ECG recordings. Data shown are mean ± SEM from 9–11 mice (*P < 0.05, vs WT).
Figure 8. PLN-KO protects against stress-induced VTs in mice.
Representative ECG recordings of PLN−/− (A), PLN−/−/RyR2-R4496C+/− (B), and PLN−/−/RyR2-R4496C+/+ (C) mice before (a) and after (b) the injection of epinephrine (1.6 mg/kg) and caffeine (120 mg/kg). VT duration (%) in PLN−/−, PLN−/−/RyR2-R4496C+/−, and PLN−/−/RyR2-R4496C+/+ mice within each 3-min (D) or 30-min (E) period of ECG recordings. Data shown are mean ± SEM from 9–10 mice (*P < 0.05, vs PLN−/−).
PLN−/−/RyR2-R4496C+/− mice display no severe defects in cardiac structure
Enhanced SR Ca2+ leak as a result of overexpression of the Ca2+/calmodulin dependent protein kinase II (CaMKII) in the heart has been shown to cause severe heart failure and dilated cardiomyopathy37, 38. It would be of interest to determine whether enhanced SR Ca2+ leak as a result of PLN-KO could induce severe structural changes in the heart. To this end, we performed echocardiography on conscious WT, RyR2-R4496C+/−, PLN−/−/RyR2-R4496C+/−, and PLN−/− mice. We found that the RyR2-R4496C+/− mutation itself did not induce gross changes in cardiac structure and function (Online Table I), which is in agreement with those reported previously30, 31. We also found no severe structural defects in the PLN−/−/RyR2-R4496C+/− or PLN−/− hearts, despite the chronic SR Ca2+ overload and enhanced spontaneous Ca2+ leak (mini waves and Ca2+ sparks) in the PLN−/−/RyR2-R4496C+/− or PLN−/− cardiomyocytes. This is consistent with previous observation that PLN−/− mice show enhanced myocardial contractility but no gross defects in cardiac structure26, 39, 40. There are, however, some small differences between PLN−/−/RyR2-R4496C+/− and WT mice and between PLN−/− and WT mice (Online Table I). Thus, as with PLN−/− hearts, PLN−/−/RyR2-R4496C+/− hearts show no severe defects in cardiac structure.
DISCUSSION
A novel and surprising finding of the present study is that, despite severe SR Ca2+ leak, PLN-KO mice are not susceptible to stress-induced VTs. In fact, on the contrary, PLN-KO protects a mouse model harbouring the CPVT-causing RyR2-R4496C mutation from stress-induced VTs. Single cell and intact heart Ca2+ imaging reveal that PLN-KO effectively breaks the cell-wide propagating SCWs into mini-waves and Ca2+ sparks. Furthermore, PLN-KO markedly suppresses SCW-evoked triggered activities in RyR2-R4496C mutant ventricular myocytes. These observations indicate that spontaneous SR Ca2+ leak in the forms of mini-waves and Ca2+ sparks (leaky SR) without generating cell-wide propagating SCWs is not necessarily linked to triggered activities and triggered arrhythmias. Our data suggest that breaking up cell-wide propagating SCWs into mini-waves and Ca2+ sparks is protective against Ca2+ triggered arrhythmias.
An important question is how PLN-KO rescues the CPVT phenotype of the RyR2-R4496C mutant mice in the face of severe diastolic SR Ca2+ leak? Increased SR Ca2+ leak is often observed in cardiomyocytes from heart failure and is thought to be a major cause of Ca2+ triggered arrhythmias12–14. This is because diastolic SR Ca2+ leak can alter the membrane potential via the activation of the electrogenic Na+/Ca2+ exchanger (NCX), resulting in DADs. These DADs can potentially trigger ectopic APs that in turn can lead to triggered arrhythmia8, 10–12. However, whether a DAD is able to trigger an AP depends on its amplitude. An AP is triggered when the amplitude of a DAD reaches the activation threshold for Na+ channels. Furthermore, the amplitude of DADs is dependent on the amplitude and rate of rise of spontaneous SR Ca2+ release10, 34. It has been estimated that a total SR Ca2+ release of 50–70% of the SR Ca2+ load is required to generate DADs with amplitudes sufficient to produce an AP10. Therefore, the small diastolic SR Ca2+ leak in the form of brief, localized Ca2+ sparks or even mini-waves themselves are unlikely to produce DADs with amplitudes that are high enough to cause triggered activities. It is the SR Ca2+ overload induced cell-wide propagating SCWs that are capable of producing triggered activities. In accordance with this view, we detected a large number of small DADs but only a few triggered APs in PLN−/−/RyR2-R4496C+/− ventricular myocytes that displayed severe SR Ca2+ leak in the form of Ca2+ sparks and mini-waves. On the other hand, we observed a number of triggered APs in RyR2-R4496C+/− ventricular myocytes that exhibited cell-wide propagating SCWs. Interestingly, triggered APs were readily detected in PLN−/−/RyR2-R4496C+/− ventricular myocytes after transforming mini-waves to cell-wide propagating SCWs by partially inhibiting SERCA2a with tBHQ. On the other hand, increasing the activity of LTCC with Bay K or the activity of RyR2 with caffeine or decreasing the activity of NCX with Li+ failed to convert mini-waves to cell-wide SCWs in PLN−/−/RyR2-R4496C+/− ventricular myocytes. Further, we found that the SR Ca2+ content was elevated in PLN−/−/RyR2-R4496C+/− ventricular myocytes compared to that in RyR2-R4496C+/− cells. Thus, enhanced SERCA2a activity as a result of PLN-KO likely contributes to the break-up of cell-wide SCWs in PLN−/−/RyR2-R4496C+/− ventricular myocytes, rather than reduced SR Ca2+ load or altered RyR2, LTCC, or NCX activity due to potential PLN-KO induced compensatory changes. The enhanced SERCA2a activity as a result of PLN ablation would result in a rapid re-sequestration of the released Ca2+ into the SR. This would effectively buffer or reduce the cytosolic Ca2+ level that is important for the propagation of Ca2+ waves via Ca2+ induced Ca2+ release, thus limiting the spatial spread of Ca2+ waves29. This effect on SCWs would reduce the amplitude of DADs and thus decrease the propensity for triggered APs and triggered arrhythmias. It is of interest to note that Davia et al.41 have shown that adenovirus-mediated overexpression of SERCA2a in adult rabbit ventricular myocytes reduced the occurrence of aftercontractions. Our present findings are consistent with those of Davia et al. and further demonstrate that enhanced SERCA2a activity suppresses triggered activities by breaking up cell-wide SCWs.
Although PLN-KO is effective in suppressing stress-induced VTs in the CPVT RyR2-R4496C mutant mice, whether PLN-KO would be beneficial in suppressing stress-induced VTs in other animal models or in humans with CPVT remains to be determined. Albeit not specifically on stress-induced arrhythmias, a number of studies have investigated the impact of PLN-KO on heart failure and cardiomyopathies42–44. For example, it has been shown that PLN-KO rescues the heart failure and dilated cardiomyopathy phenotypes in a mouse model in which the cytoskeletal, muscle specific LIM protein (MLP) is ablated42. PLN-KO has also been shown to reverse the cardiac hypertrophy phenotype in a mouse model with calsequestrin overexpression43. However, PLN-KO does not rescue cardiac dysfunction in all mouse models of heart failure and cardiomyopathies tested45–47. For instance, it has recently been shown that despite the rescue of SR Ca2+ handling, PLN-KO exaggerates heart failure and mortality in CaMKIIδc overexpressing mice46. It was suggested that PLN deficiency in the CaMKIIδc overexpressing mice resulted in markedly increased SR Ca2+ load in the face of enhanced diastolic SR Ca2+ leak due to CaMKIIδc-dependent hyperphosphorylation of RyR2. The combination of increased SR Ca2+ load and enhanced SR Ca2+ leak predisposes cardiomyocytes to cell death and other Ca2+-mediated abnormalities. Similarly, the combination of enhanced SR Ca2+ load as a result of overexpression of the skeletal muscle SR Ca2+ ATPase (SERCA1a) or PLN-KO and increased SR Ca2+ leak as a consequence of CASQ2-KO led to myocyte apoptosis, dilated cardiomyopathy, and early mortality48. On the other hand, we found that the PLN-KO RyR2-R4496C mutant mice show no severe structural and functional defects. Thus, unlike that seen in the CaMKIIδc overexpressing mice or CASQ2-KO mice, PLN-KO does not lead to cardiac dysfunction in the PLN−/−/RyR2-R4496C+/− mice even in the face of enhanced spontaneous SR Ca2+ release. The exact reasons for this discrepancy are not clear. Spontaneous SR Ca2+ release in the CaMKIIδc-overexpressing or CASQ2-KO mice may be much more severe than that in the RyR2-R4496C+/− mice. Consistent with this view, both CaMKIIδc-overexpressing and CASQ2-KO mice, but not RyR2-R4496C+/− mice, exhibit dilated cardiomyopathy, heart failure or hypertrophy38, 49. Thus, it is possible that the enhanced SERCA2a activity as a result of PLN-KO may not be able to fully compensate for the much more severe SR Ca2+ leak caused by CaMKIIδc overexpression or CASQ2-KO, leading to chronic diastolic SR Ca2+ leak, cardiomyopathies and heart failure. Therefore, whether PLN-KO produces beneficial effects would be dependent on the cause and severity of the defects of the disease model. It is also important to note that, opposite to those observed in PLN-KO mice, PLN deficiency in humans as a result of nonsense mutations is associated with severe dilated cardiomyopathy and heart failure50. Hence, the beneficial effects of PLN-KO may also be species dependent.
In summary, we show that PLN-KO effectively breaks SCWs into mini-waves and Ca2+ sparks in mouse ventricular myocytes expressing the SCW-prone, CPVT-causing RyR2-R4496C mutant. We further show that PLN-KO markedly suppresses SCW-evoked triggered activity and completely protects the RyR2-R4496C+/− mutant mice against CPVT. Thus, as with inhibiting RyR2 activity, breaking up SCWs by enhancing SERCA2a activity represents an effective means in suppressing Ca2+ triggered arrhythmias.
Limitations
In this study, we used confocal linescan imaging to estimate and compare the SR Ca2+ contents in cardiomyocytes with different genotypes by measuring the amplitude of caffeine evoked Ca2+ transients. Although this approach yielded useful information on the relative SR Ca2+ contents of different groups of cells, it did not provide a quantitative assessment of the SR Ca2+ content. Further, the amplitude of caffeine evoked Ca2+ transients could be influenced by various factors such as cytosolic Ca2+ buffering. Since increased SERCA2a activity as a result of PLN ablation would enhance the removal of cytosolic Ca2+ (equivalent to increased cytosolic Ca2+ buffering), the increase in the relative SR Ca2+ content detected in PLN−/−/R4496C+/− cells would have been underestimated due to this increased Ca2+ removal/buffering. However, since PLN ablation increases the SR Ca2+ content in PLN−/−/R4496C+/− cardiomyocytes, the lack of cell-wide propagating SCWs in these cells is unlikely to be due to a reduced SR Ca2+ content.
Supplementary Material
Novelty and Significance.
What Is Known?
Spontaneous Ca2+ waves (SCWs) are a major cause of Ca2+-mediated arrhythmias.
Mutations in the cardiac ryanodine receptor (RyR2) associated with catecholaminergic polymorphic ventricular tachycardia (CPVT)- enhance the propensity for SCWs.
Ablation of phospholamban (PLN), an inhibitor of sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA2a), increases sarcoplasmic reticulum (SR) Ca2+ leak, but aborts SCWs.
What New Information Does This Article Contribute?
PLN ablation breaks cell-wide propagating SCWs into mini-waves and Ca2+ sparks in intact CPVT RyR2 mutant hearts.
Despite markedly increased SR Ca2+ leak, PLN ablation protects against CPVT in RyR2 mutant mice.
Breaking up SCWs by enhancing Ca2+ uptake represents an effective means for suppressing Ca2+-mediated arrhythmias.
Enhanced SR Ca2+ sequestration as a result of PLN ablation has been shown, on one hand, to increase potentially arrhythmogenic SR Ca2+ leak, but, on the other hand, to abort SCWs that could lead to triggered activity. These seemingly paradoxical actions raise an important question as to whether enhanced SR Ca2+ sequestration is pro-arrhythmic or anti-arrhythmic. To this end, we assessed the effect of PLN ablation on SR Ca2+ leak, SCWs, triggered activity, and stress-induced ventricular tachycardia’s (VTs) in a mouse model of CPVT. We found that enhanced SR Ca2+ uptake as a consequence of PLN ablation fragmented cell-wide propagating SCWs, but increased SR Ca2+ leak in the forms of mini-waves and Ca2+ sparks. Despite the presence of severe SR Ca2+ leak, PLN ablation suppressed triggered activity evoked by SR Ca2+ overload and protected CPVT-associated RyR2 mutant mice from stress-induced VTs. Our data show that enhancing SR Ca2+ sequestration suppresses CPVT in mice. These observations suggest that breaking up cell-wide propagating SCWs either by reducing the duration of RyR2 openings or by enhancing SR Ca2+ sequestration represents a promising strategy for suppressing Ca2+ mediated cardiac arrhythmias.
ACKNOWLEDGEMENTS
We would like to thank Dr. Evangelia Kranias for kindly providing the PLN-KO mice, Dr. Jonathan Lytton for the gift of the anti-SERCA2a and anti-NCX antibodies, and Dr. Wayne Giles for his support for the patch clamp experiments
SOURCES OF FUNDING
This work was supported by research grants from the Alberta Heritage Foundation for Medical Research (PPJ), Heart and Stroke Foundation of Alberta, Northwest Territories and Nunavut (SRWC, PPJ), the Canada Foundation for Innovation (CFI) (SRWC), the Canadian Institutes of Health Research (HJD and SRWC), the National Institutes of Health (R01HL75210 to SRWC) and (R01HL090905 to LSS), and the Spanish Ministry of Science and Innovation DPI2009-06999 (RB), CNIC2009-08 (LHM) and SAF2011-30312 (LHM). P.P.J. is recipient of the Alberta Innovates-Health Solutions (AIHS) Postdoctoral Fellowship Award.
Nonstandard Abbreviations and Acronyms
- RyR2
cardiac ryanodine receptor
- CPVT
catecholaminergic polymorphic ventricular tachycardia
- DAD
delayed afterdepolarization
- PLN
phospholamban
- SR
sarcoplasmic recticulum
- SCWs
spontaneous Ca2+ waves
- SERCA2a
cardiac sarco(endo)plasmic recticulum Ca2+-ATPase
- AP
action potential
- tBHQ
2,5-Di-tert-butylhydroquinone
- CASQ2
cardiac calsequestrin
- LTCC
L-type Ca2+ Channel
- Na+/Ca2+
sodium/calcium exchange
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
DISCLOSURES
None.
References
- 1.Fabiato A. Calcium-induced release of calcium from the cardiac sarcoplasmic reticulum. Am J Physiol. 1983;245:C1–C14. doi: 10.1152/ajpcell.1983.245.1.C1. [DOI] [PubMed] [Google Scholar]
- 2.Bers DM. Cardiac excitation-contraction coupling. Nature. 2002;415:198–205. doi: 10.1038/415198a. [DOI] [PubMed] [Google Scholar]
- 3.Fill M, Copello JA. Ryanodine receptor calcium release channels. Physiol Rev. 2002;82:893–922. doi: 10.1152/physrev.00013.2002. [DOI] [PubMed] [Google Scholar]
- 4.Kass RS, Tsien RW. Fluctuations in membrane current driven by intracellular calcium in cardiac purkinje fibers. Biophys J. 1982;38:259–269. doi: 10.1016/S0006-3495(82)84557-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Stern M, Kort A, Bhatnagar G, Lakatta E. Scattered-light intensity fluctuations in diastolic rat cardiac muscle caused by spontaneous Ca2+-dependent cellular mechanical oscillations. J Gen Physiol. 1983;82:119–153. doi: 10.1085/jgp.82.1.119. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Orchard C, Eisner D, Allen D. Oscillations of intracellular Ca2+ in mammalian cardiac muscle. Nature. 1983;304:735–738. doi: 10.1038/304735a0. [DOI] [PubMed] [Google Scholar]
- 7.Marban E, Robinson SW, Wier WG. Mechanisms of arrhythmogenic delayed and early afterdepolarizations in ferret ventricular muscle. J Clin Invest. 1986;78:1185–1192. doi: 10.1172/JCI112701. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Lakatta EG. Functional implications of spontaneous sarcoplasmic reticulum Ca2+ release in the heart. Cardiovasc Res. 1992;26:193–214. doi: 10.1093/cvr/26.3.193. [DOI] [PubMed] [Google Scholar]
- 9.Lakatta EG, Guarnieri T. Spontaneous myocardial calcium oscillations: Are they linked to ventricular fibrillation? J Cardiovasc Electrophysiol. 1993;4:473–489. doi: 10.1111/j.1540-8167.1993.tb01285.x. [DOI] [PubMed] [Google Scholar]
- 10.Schlotthauer K, Bers DM. Sarcoplasmic reticulum Ca2+ release causes myocyte depolarization. underlying mechanism and threshold for triggered action potentials. Circ Res. 2000;87:774–780. doi: 10.1161/01.res.87.9.774. [DOI] [PubMed] [Google Scholar]
- 11.Bers DM. Calcium and cardiac rhythms: Physiological and pathophysiological. Circ Res. 2002;90:14–17. [PubMed] [Google Scholar]
- 12.Pogwizd SM, Bers DM. Cellular basis of triggered arrhythmias in heart failure. Trends Cardiovasc Med. 2004;14:61–66. doi: 10.1016/j.tcm.2003.12.002. [DOI] [PubMed] [Google Scholar]
- 13.Nuss HB, Kaab S, Kass DA, Tomaselli GF, Marban E. Cellular basis of ventricular arrhythmias and abnormal automaticity in heart failure. Am J Physiol Heart Circ Physiol. 1999;277:H80–H91. doi: 10.1152/ajpheart.1999.277.1.H80. [DOI] [PubMed] [Google Scholar]
- 14.Zaugg C, Buser P. When calcium turns arrhythmogenic: Intracellular calcium handling during the development of hypertrophy and heart failure. Croat Med J. 2001;42:24–32. [PubMed] [Google Scholar]
- 15.Priori SG, Chen SR. Inherited dysfunction of sarcoplasmic reticulum Ca2+ handling and arrhythmogenesis. Circ Res. 2011;108:871–883. doi: 10.1161/CIRCRESAHA.110.226845. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Venetucci LA, Trafford AW, Diaz ME, O'Neill SC, Eisner DA. Reducing ryanodine receptor open probability as a means to abolish spontaneous Ca2+ release and increase Ca2+ transient amplitude in adult ventricular myocytes. Circ Res. 2006;98:1299–1305. doi: 10.1161/01.RES.0000222000.35500.65. [DOI] [PubMed] [Google Scholar]
- 17.Watanabe H, Chopra N, Laver D, Hwang HS, Davies SS, Roach DE, Duff HJ, Roden DM, Wilde AA, Knollmann BC. Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans. Nat Med. 2009;15:380–383. doi: 10.1038/nm.1942. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Hilliard FA, Steele DS, Laver D, Yang Z, Le Marchand SJ, Chopra N, Piston DW, Huke S, Knollmann BC. Flecainide inhibits arrhythmogenic Ca2+ waves by open state block of ryanodine receptor Ca2+ release channels and reduction of Ca2+ spark mass. J Mol Cell Cardiol. 2010;48:293–301. doi: 10.1016/j.yjmcc.2009.10.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Galimberti ES, Knollmann BC. Efficacy and potency of class I antiarrhythmic drugs for suppression of Ca2+ waves in permeabilized myocytes lacking calsequestrin. J Mol Cell Cardiol. 2011;51:760–768. doi: 10.1016/j.yjmcc.2011.07.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Zhou Q, Xiao J, Jiang D, Wang R, Vembaiyan K, Wang A, Smith CD, Xie C, Chen W, Zhang J, Tian X, Jones PP, Zhong X, Guo A, Chen H, Zhang L, Zhu W, Yang D, Li X, Chen J, Gillis AM, Duff HJ, Cheng H, Feldman AM, Song LS, Fill M, Back TG, Chen SR. Carvedilol and its new analogs suppress arrhythmogenic store overload-induced Ca2+ release. Nat Med. 2011;17:1003–1009. doi: 10.1038/nm.2406. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Lukyanenko V, Subramanian S, Gyorke I, Wiesner TF, Gyorke S. The role of luminal Ca2+ in the generation of Ca2+ waves in rat ventricular myocytes. J Physiol. 1999;518(Pt 1):173–186. doi: 10.1111/j.1469-7793.1999.0173r.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Landgraf G, Gellerich FN, Wussling MH. Inhibitors of SERCA and mitochondrial ca-uniporter decrease velocity of calcium waves in rat cardiomyocytes. Mol Cell Biochem. 2004;256:257–379. doi: 10.1023/b:mcbi.0000009883.71379.51. [DOI] [PubMed] [Google Scholar]
- 23.O'Neill SC, Miller L, Hinch R, Eisner DA. Interplay between SERCA and sarcolemmal Ca2+ efflux pathways controls spontaneous release of Ca2+ from the sarcoplasmic reticulum in rat ventricular myocytes. J Physiol. 2004;559:121–128. doi: 10.1113/jphysiol.2003.058917. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Keller M, Kao JP, Egger M, Niggli E. Calcium waves driven by "sensitization" wave-fronts. Cardiovasc Res. 2007;74:39–45. doi: 10.1016/j.cardiores.2007.02.006. [DOI] [PubMed] [Google Scholar]
- 25.Maxwell JT, Blatter LA. Facilitation of cytosolic calcium wave propagation by local calcium uptake into the sarcoplasmic reticulum in cardiac myocytes. J Physiol. 2012;590(Pt 23):6037–6045. doi: 10.1113/jphysiol.2012.239434. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Luo W, Grupp IL, Harrer J, Ponniah S, Grupp G, Duffy JJ, Doetschman T, Kranias EG. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation. Circ Res. 1994;75:401–409. doi: 10.1161/01.res.75.3.401. [DOI] [PubMed] [Google Scholar]
- 27.Santana LF, Kranias EG, Lederer WJ. Calcium sparks and excitation-contraction coupling in phospholamban-deficient mouse ventricular myocytes. J Physiol. 1997;503(Pt 1):21–29. doi: 10.1111/j.1469-7793.1997.021bi.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Li Y, Kranias EG, Mignery GA, Bers DM. Protein kinase A phosphorylation of the ryanodine receptor does not affect calcium sparks in mouse ventricular myocytes. Circ Res. 2002;90:309–316. doi: 10.1161/hh0302.105660. [DOI] [PubMed] [Google Scholar]
- 29.Huser J, Bers DM, Blatter LA. Subcellular properties of [Ca2+]i transients in phospholamban-deficient mouse ventricular cells. Am J Physiol. 1998;274:H1800–H1811. doi: 10.1152/ajpheart.1998.274.5.H1800. [DOI] [PubMed] [Google Scholar]
- 30.Cerrone M, Colombi B, Santoro M, di Barletta MR, Scelsi M, Villani L, Napolitano C, Priori SG. Bidirectional ventricular tachycardia and fibrillation elicited in a knock-in mouse model carrier of a mutation in the cardiac ryanodine receptor. Circ Res. 2005;96:e77–e82. doi: 10.1161/01.RES.0000169067.51055.72. [DOI] [PubMed] [Google Scholar]
- 31.Liu N, Colombi B, Memmi M, Zissimopoulos S, Rizzi N, Negri S, Imbriani M, Napolitano C, Lai FA, Priori SG. Arrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia: Insights from a RyR2 R4496C knock-in mouse model. Circ Res. 2006;99:292–298. doi: 10.1161/01.RES.0000235869.50747.e1. [DOI] [PubMed] [Google Scholar]
- 32.Sedej S, Heinzel FR, Walther S, Dybkova N, Wakula P, Groborz J, Gronau P, Maier LS, Vos MA, Anthony Lai F, Napolitano C, Priori SG, Kockskamper J, Pieske B. Na+-dependent SR Ca2+ overload induces arrhythmogenic events in mouse cardiomyocytes with a human CPVT mutation. Cardiovasc Res. 2010;87(1):50–59. doi: 10.1093/cvr/cvq007. [DOI] [PubMed] [Google Scholar]
- 33.Chen B, Guo A, Gao Z, Wei S, Xie YP, Chen SR, Anderson ME, Song LS. In situ confocal imaging in intact heart reveals stress-induced Ca2+ release variability in a murine catecholaminergic polymorphic ventricular tachycardia model of type 2 ryanodine receptor (R4496C+/-) mutation. Circ Arrhythm Electrophysiol. 2012;5:841–849. doi: 10.1161/CIRCEP.111.969733. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Hoeker GS, Katra RP, Wilson LD, Plummer BN, Laurita KR. Spontaneous calcium release in tissue from the failing canine heart. Am J Physiol Heart Circ Physiol. 2009;297:H1235–H1242. doi: 10.1152/ajpheart.01320.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Venetucci LA, Trafford AW, Eisner DA. Increasing ryanodine receptor open probability alone does not produce arrhythmogenic calcium waves: Threshold sarcoplasmic reticulum calcium content is required. Circ Res. 2007;100:105–111. doi: 10.1161/01.RES.0000252828.17939.00. [DOI] [PubMed] [Google Scholar]
- 36.Kashimura T, Briston SJ, Trafford AW, Napolitano C, Priori SG, Eisner DA, Venetucci LA. In the RyR2(R4496C) mouse model of CPVT, beta-adrenergic stimulation induces ca waves by increasing SR ca content and not by decreasing the threshold for ca waves. Circ Res. 2010;107:1483–1489. doi: 10.1161/CIRCRESAHA.110.227744. [DOI] [PubMed] [Google Scholar]
- 37.Maier LS, Zhang T, Chen L, DeSantiago J, Brown JH, Bers DM. Transgenic CaMKII{delta}C overexpression uniquely alters cardiac myocyte Ca2+ handling: Reduced SR Ca2+ load and activated SR Ca2+ release. Circ Res. 2003;92:904–911. doi: 10.1161/01.RES.0000069685.20258.F1. [DOI] [PubMed] [Google Scholar]
- 38.Zhang T, Maier LS, Dalton ND, Miyamoto S, Ross J, Jr, Bers DM, Brown JH. The {delta}C isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure. Circ Res. 2003;92:912–919. doi: 10.1161/01.RES.0000069686.31472.C5. [DOI] [PubMed] [Google Scholar]
- 39.Hoit BD, Khoury SF, Kranias EG, Ball N, Walsh RA. In vivo echocardiographic detection of enhanced left ventricular function in gene-targeted mice with phospholamban deficiency. Circ Res. 1995;77:632–637. doi: 10.1161/01.res.77.3.632. [DOI] [PubMed] [Google Scholar]
- 40.Chu G, Ferguson DG, Edes I, Kiss E, Sato Y, Kranias EG. Phospholamban ablation and compensatory responses in the mammalian heart. Ann N Y Acad Sci. 1998;853:49–62. doi: 10.1111/j.1749-6632.1998.tb08256.x. [DOI] [PubMed] [Google Scholar]
- 41.Davia K, Bernobich E, Ranu HK, del Monte F, Terracciano CM, MacLeod KT, Adamson DL, Chaudhri B, Hajjar RJ, Harding SE. SERCA2A overexpression decreases the incidence of aftercontractions in adult rabbit ventricular myocytes. J Mol Cell Cardiol. 2001;33:1005–1015. doi: 10.1006/jmcc.2001.1368. [DOI] [PubMed] [Google Scholar]
- 42.Minamisawa S, Hoshijima M, Chu G, Ward CA, Frank K, Gu Y, Martone ME, Wang Y, Ross J, Jr, Kranias EG, Giles WR, Chien KR. Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy. Cell. 1999;99:313–322. doi: 10.1016/s0092-8674(00)81662-1. [DOI] [PubMed] [Google Scholar]
- 43.Sato Y, Kiriazis H, Yatani A, Schmidt AG, Hahn H, Ferguson DG, Sako H, Mitarai S, Honda R, Mesnard-Rouiller L, Frank KF, Beyermann B, Wu G, Fujimori K, Dorn GW, 2nd, Kranias EG. Rescue of contractile parameters and myocyte hypertrophy in calsequestrin overexpressing myocardium by phospholamban ablation. J Biol Chem. 2001;276:9392–9399. doi: 10.1074/jbc.M006889200. [DOI] [PubMed] [Google Scholar]
- 44.Engelhardt S, Hein L, Dyachenkow V, Kranias EG, Isenberg G, Lohse MJ. Altered calcium handling is critically involved in the cardiotoxic effects of chronic beta-adrenergic stimulation. Circulation. 2004;109:1154–1160. doi: 10.1161/01.CIR.0000117254.68497.39. [DOI] [PubMed] [Google Scholar]
- 45.Song Q, Schmidt AG, Hahn HS, Carr AN, Frank B, Pater L, Gerst M, Young K, Hoit BD, McConnell BK, Haghighi K, Seidman CE, Seidman JG, Dorn GW, 2nd, Kranias EG. Rescue of cardiomyocyte dysfunction by phospholamban ablation does not prevent ventricular failure in genetic hypertrophy. J Clin Invest. 2003;111:859–867. doi: 10.1172/JCI16738. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Zhang T, Guo T, Mishra S, Dalton ND, Kranias EG, Peterson KL, Bers DM, Brown JH. Phospholamban ablation rescues sarcoplasmic reticulum ca(2+) handling but exacerbates cardiac dysfunction in CaMKIIdelta(C) transgenic mice. Circ Res. 2010;106:354–362. doi: 10.1161/CIRCRESAHA.109.207423. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Shanmugam M, Gao S, Hong C, Fefelova N, Nowycky MC, Xie LH, Periasamy M, Babu GJ. Ablation of phospholamban and sarcolipin results in cardiac hypertrophy and decreased cardiac contractility. Cardiovasc Res. 2011;89:353–361. doi: 10.1093/cvr/cvq294. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Kalyanasundaram A, Lacombe VA, Belevych AE, Brunello L, Carnes CA, Janssen PM, Knollmann BC, Periasamy M, Gyorke S. Upregulation of sarcoplasmic reticulum Ca2+ uptake leads to cardiac hypertrophy, contractile dysfunction and early mortality in mice deficient in CASQ2. Cardiovasc Res. 2012 doi: 10.1093/cvr/cvs334. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Knollmann BC, Chopra N, Hlaing T, Akin B, Yang T, Ettensohn K, Knollmann BE, Horton KD, Weissman NJ, Holinstat I, Zhang W, Roden DM, Jones LR, Franzini-Armstrong C, Pfeifer K. Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardia. J Clin Invest. 2006;116:2510–2520. doi: 10.1172/JCI29128. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Haghighi K, Kolokathis F, Pater L, Lynch RA, Asahi M, Gramolini AO, Fan GC, Tsiapras D, Hahn HS, Adamopoulos S, Liggett SB, Dorn GW, 2nd, MacLennan DH, Kremastinos DT, Kranias EG. Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human. J Clin Invest. 2003;111:869–876. doi: 10.1172/JCI17892. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.








